Shiraishi Masayuki, Oshiro Takashi, Nozato Eiji, Nagahama Masayoshi, Taira Kaoru, Nomura Hironori, Sugawa Hideki, Muto Yoshihiro
First Department of Surgery, University of the Ryukyus, School of Medicine, Uehara 207, Nishihara-cho, Okinawa 903-0215, Japan.
Transpl Int. 2002 May;15(5):212-9. doi: 10.1007/s00147-002-0405-1. Epub 2002 Apr 11.
In this study, the adenovirus-mediated gene transfer of triple human complement regulating proteins was investigated in xenogeneic pig liver perfusion. The porcine liver was perfused in situ at 4 degrees C under a pump-driven veno-venous shunt of the portal vein and inferior vena cava, with 5 to 15x10(11) plaque-forming units (pfu) of adenovirus vector (group 1: AxCALacZ; 2: AxCACD59; 3: AxCACD59 + AxCADAF; 4: AxCACD59 + AxCADAF + AxCAMCP) for 1 h (for each, n=3). The livers were harvested 24 h after gene transfer and then were reperfused ex-vivo with fresh human blood for 2 h. In immunohistochemical staining, each complement regulating protein (CRP) showed a distribution similar to that of the LacZ expression. The C3 levels in the perfusate were also maintained at higher levels in group 4 from 60 to 120 min after reperfusion (C3: 85% to 95% of the initial level) than in groups 1 to 3 (C3: 80% to 90% of the initial level) from 60 to 120 min after reperfusion. The complement deposition on the porcine liver [C3, membrane attack component (MAC)] decreased significantly more in group 4 than in groups 1 to 3. In conclusion, the adenovirus-mediated multiple gene transfer of human CRPs (hCRPs) was found to effectively suppress the complement activation in xenogeneic pig liver perfusion.
在本研究中,对腺病毒介导的三种人类补体调节蛋白基因转移在异种猪肝灌注中的情况进行了研究。在门静脉和下腔静脉的泵驱动静脉-静脉分流下,于4℃对猪肝进行原位灌注,分别给予5至15×10¹¹ 个腺病毒载体噬斑形成单位(pfu)(第1组:AxCALacZ;第2组:AxCACD59;第3组:AxCACD59 + AxCADAF;第4组:AxCACD59 + AxCADAF + AxCAMCP),持续1小时(每组n = 3)。基因转移24小时后收获肝脏,然后用新鲜人血进行2小时的离体再灌注。在免疫组织化学染色中,每种补体调节蛋白(CRP)的分布与LacZ表达的分布相似。再灌注后60至120分钟,第4组灌注液中的C3水平也维持在较高水平(C3:初始水平的85%至95%),高于第1至3组(C3:初始水平的80%至90%)。第4组猪肝上补体沉积[C3、膜攻击复合物(MAC)]的减少幅度明显大于第1至3组。总之,发现腺病毒介导的人类CRP(hCRP)多基因转移能有效抑制异种猪肝灌注中的补体激活。